Pharming Group to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Rhea-AI Summary

Pharming Group (PHARM) will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference virtually on February 25-26, 2026. Management presentation by CEO Fabrice Chouraqui and CMO Anurag Relan is scheduled for February 25 at 12:40pm ET / 18:40 CET.

A live webcast and replay will be available in the company’s Upcoming Events and News sections. One-on-one investor meetings can be arranged via investor@pharming.com or through Oppenheimer representatives.

Key Figures

Conference edition: 36th Conference dates: February 25-26, 2026 Presentation date: February 25, 2026 +2 more

5 metrics

Conference edition 36th Oppenheimer Annual Healthcare Life Sciences Conference

Conference dates February 25-26, 2026 Virtual Oppenheimer Healthcare Life Sciences Conference

Presentation date February 25, 2026 Company presentation timing at conference

Presentation time ET 12:40pm ET Scheduled CEO and CMO presentation

Presentation time CET 18:40 CET Scheduled CEO and CMO presentation

Market Reality Check

normal vol

Market Pulse Summary

This announcement highlighted Pharming’s participation in a major healthcare investor conference, wi...

Analysis

This announcement highlighted Pharming’s participation in a major healthcare investor conference, with management presenting on February 25, 2026. The event offered a venue for outlining strategy and clinical or commercial priorities to institutional investors via webcast. Investors following this type of news typically monitor subsequent communications, updated presentations, and any follow-on meetings or coverage that may emerge from such conference participation.

AI-generated analysis. Not financial advice.

Leiden, the Netherlands, February 17, 2026: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announced its participation in the Oppenheimer 36^th Annual Healthcare Life Sciences Conference being held virtually on February 25-26, 2026.

Fabrice Chouraqui, Chief Executive Officer, and Anurag Relan, M.D., Chief Medical Officer, will present on Wednesday, February 25 at 12:40pm ET/18:40 CET. A live webcast and replay of the presentation will be made available in the “Upcoming Events” and “News” sections of Pharming’s website.

To schedule a one-on-one meeting with Pharming’s management team, please contact Investor Relations at investor@pharming.com or your Oppenheimer representative.

About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are developing and commercializing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, with a significant proportion of its employees based in the U.S.

For more information, visit www.pharming.com and find us on LinkedIn.

For further public information, contact:
Investor Relations
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: investor@pharming.com

Media Relations
Global: Saskia Mehring, Corporate Communications Manager
T: +31 6 28 32 60 41
E: media.relations@pharming.com

U.S.: Ethan Metelenis (Precision AQ on behalf of Pharming)
T: +1 (917) 882-9038

Netherlands: Leon Melens (LifeSpring Life Sciences Communication on behalf of Pharming)
T: +31 6 53 81 64 27

Attachment

• Pharming to present at Oppenheimer Healthcare Life Sciences Conference_EN_17FEB2026

FAQ

When will Pharming Group (PHARM) present at the Oppenheimer conference in February 2026?

Pharming will present on February 25, 2026 at 12:40pm ET / 18:40 CET. According to Pharming, CEO Fabrice Chouraqui and CMO Anurag Relan will lead the presentation and answer investor questions during the virtual session.

How can investors watch the Pharming (PHARM) presentation from Oppenheimer 36th Annual Healthcare conference?

Investors can watch via a live webcast and later replay in the company’s Upcoming Events and News sections. According to Pharming, the webcast will be posted on Pharming’s website for on-demand viewing after the live presentation.

Can I schedule a one-on-one meeting with Pharming (PHARM) management at the Oppenheimer conference?

Yes, one-on-one meetings can be scheduled by contacting investor@pharming.com or your Oppenheimer representative. According to Pharming, Investor Relations will coordinate meeting requests with CEO Fabrice Chouraqui and CMO Anurag Relan during the conference.

Who from Pharming (PHARM) will present at the Oppenheimer Healthcare Life Sciences Conference?

Pharming’s presentation will be delivered by CEO Fabrice Chouraqui and CMO Anurag Relan. According to Pharming, both executives will present company developments and be available for investor engagement on February 25, 2026.

Where will the Pharming (PHARM) webcast and replay be posted after the Oppenheimer presentation?

The webcast and replay will be posted in the company’s Upcoming Events and News sections on its website. According to Pharming, those pages will host the live stream and on‑demand replay following the February 25 presentation.

What time is Pharming’s (PHARM) presentation in Central European Time at the Oppenheimer conference?

Pharming’s presentation is scheduled for 18:40 CET on February 25, 2026. According to Pharming, that corresponds to the 12:40pm ET start time for the virtual presentation led by company executives.